Product Information
DISOPYRAMIDE 150 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.5006 per EA under NDC 59762040001. Its NADAC has been published 355 times since Jun 12, 2019.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762040001
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DISOPYRAMIDE PHOSPHATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017447FDA Approved
Before 1982
TE Code
AB
On Market Since
4/23/2019
Pharmacological Classes
Price Statistics
The NADAC for DISOPYRAMIDE 150 MG CAPSULE has been published 355 times since Jun 12, 2019, and over the history we have for it it has declined 14.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5006 per EA |
|---|---|
| All-time high | $1.7871 (May 15, 2024) |
| All-time low | $1.0595 (Jan 22, 2025) |
| 52-week high | $1.7091 |
| 52-week low | $1.4907 |
| Median price | $1.4907 |
| Average price | $1.5022 |
| Largest weekly change | -22.9% (Nov 20, 2024) |
| Weeks tracked | 355 |
| Tracking since | Jun 12, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DISOPYRAMIDE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DISOPYRAMIDE 150 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $1.5006 per EA (NDC 59762040001), effective Aug 19, 2026.
How has the price of DISOPYRAMIDE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DISOPYRAMIDE 150 MG CAPSULE has declined 14.4%. It has been tracked across 355 weekly CMS publications since Jun 12, 2019.
What are the highest and lowest recorded NADAC prices for DISOPYRAMIDE 150 MG CAPSULE?
Since Jun 12, 2019, the NADAC for DISOPYRAMIDE 150 MG CAPSULE has ranged from a low of $1.0595 (Jan 22, 2025) to a high of $1.7871 (May 15, 2024), with a median of $1.4907 per EA.
Are there cheaper alternatives to DISOPYRAMIDE 150 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DISOPYRAMIDE 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DISOPYRAMIDE 150 MG CAPSULE?
DISOPYRAMIDE 150 MG CAPSULE (NDC 59762040001) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.